<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34296769</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4598</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Muscle &amp; nerve</Title><ISOAbbreviation>Muscle Nerve</ISOAbbreviation></Journal><ArticleTitle>Assessment of dysarthria and dysphagia in patients with amyotrophic lateral sclerosis: Review of the current evidence.</ArticleTitle><Pagination><StartPage>520</StartPage><EndPage>531</EndPage><MedlinePgn>520-531</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/mus.27361</ELocationID><Abstract><AbstractText>Bulbar dysfunction is a common presentation of amyotrophic lateral sclerosis (ALS) and significantly impacts quality of life of people with ALS (PALS). The current paper reviews measurements of dysarthria and dysphagia specific to ALS to identify efficient and valid assessment measures. Using such assessment measures will lead to improved management of bulbar dysfunction in ALS. Measures reviewed for dysarthria in PALS are organized into three categories: acoustic, kinematic, and strength. A set of criteria are used to evaluate the effectiveness of the measures' identification of speech impairments, measurement of functional verbal communication, and clinical applicability. Assessments reviewed for dysphagia in PALS are organized into six categories: patient reported outcomes, dietary intake, pulmonary function and airway defense capacity, bulbar function, dysphagia/aspiration screens, and instrumental evaluations. Measurements that have good potential for clinical use are highlighted in both topic areas. Additionally, areas of improvement for clinical practice and research are identified and discussed. In general, no single speech measure fulfilled all the criteria, although a few measures were identified as potential diagnostic tools. Similarly, few objective measures that were validated and replicated with large sample sizes were found for diagnosis of dysphagia in PALS. Importantly, clinical applicability was found to be limited; thus, a collaborative team focused on implementation science would be helpful to improve the clinical uptake of assessments. Overall, the review highlights the need for further development of clinically viable and efficient measurements that use a multidisciplinary approach.</AbstractText><CopyrightInformation>&#xa9; 2021 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jimin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Communication Sciences and Disorders, The Pennsylvania State University, University Park, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madhavan</LastName><ForeName>Aarthi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Communication Sciences and Disorders, The Pennsylvania State University, University Park, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krajewski</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Communication Sciences and Disorders, The Pennsylvania State University, University Park, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lingenfelter</LastName><ForeName>Sydney</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Communication Sciences and Disorders, The Pennsylvania State University, University Park, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Muscle Nerve</MedlineTA><NlmUniqueID>7803146</NlmUniqueID><ISSNLinking>0148-639X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003680" MajorTopicYN="Y">Deglutition Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004401" MajorTopicYN="N">Dysarthria</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013060" MajorTopicYN="N">Speech</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">assessment</Keyword><Keyword MajorTopicYN="N">bulbar function</Keyword><Keyword MajorTopicYN="N">dysarthria</Keyword><Keyword MajorTopicYN="N">dysphagia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>23</Day><Hour>8</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34296769</ArticleId><ArticleId IdType="doi">10.1002/mus.27361</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4:1-22.</Citation></Reference><Reference><Citation>Felgoise SH, Zaccheo V, Duff J, Simmons Z. Verbal communication impacts quality of life in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:179-183.</Citation></Reference><Reference><Citation>Weismer G, Yunusova Y, Bunton K. Measures to evaluate the effects of DBS on speech production. J Neurolinguistics. 2012;25:74-94.</Citation></Reference><Reference><Citation>Pattee GL, Plowman EK, Garand KL, et al. Provisional best practices guidelines for the evaluation of bulbar dysfunction in amyotrophic lateral sclerosis. Muscle Nerve. 2019;59:531-536.</Citation></Reference><Reference><Citation>Allison KM, Yunusova Y, Green JR. Shorter sentence length maximizes intelligibility and speech motor performance in persons with dysarthria due to amyotrophic lateral sclerosis. Am J Speech Lang Pathol. 2019;28:96-107.</Citation></Reference><Reference><Citation>Kent JF, Kent RD, Rosenbek JC, et al. Quantitative description of the dysarthria in women with amyotrophic lateral sclerosis. J Speech Lang Hear Res. 1992;35:723-733.</Citation></Reference><Reference><Citation>Lee J, Dickey E, Simmons Z. Vowel-specific intelligibility and acoustic patterns in individuals with dysarthria secondary to amyotrophic lateral sclerosis. J Speech Lang Hear Res. 2019;62:34-59.</Citation></Reference><Reference><Citation>Lee J, Fischer JC. Single word-based acoustic vowel space in individuals with dysarthria secondary to amyotrophic lateral sclerosis. Perspectives of the ASHA Special Interest Groups. 2019;4:1171-1188.</Citation></Reference><Reference><Citation>Mulligan M, Carpenter J, Riddel J, et al. Intelligibility and the acoustic characteristics of speech in amyotrophic lateral sclerosis (ALS). J Speech Lang Hear Res. 1994;37:496-503.</Citation></Reference><Reference><Citation>Nevler N, Ash S, McMillan C, et al. Automated analysis of natural speech in amyotrophic lateral sclerosis spectrum disorders. Neurology. 2020;95:e1629-e1639.</Citation></Reference><Reference><Citation>Rong P. Automated acoustic analysis of oral diadochokinesis to assess bulbar motor involvement in amyotrophic lateral sclerosis. J Speech Lang Hear Res. 2020;63:59-73.</Citation></Reference><Reference><Citation>Tjaden K, Turner GS. Spectral properties of fricatives in amyotrophic lateral sclerosis. J Speech Lang Hear Res. 1997;40:1358-1372.</Citation></Reference><Reference><Citation>Turner GS, Tjaden K. Acoustic differences between content and function words in amyotrophic lateral sclerosis. J Speech Lang Hear Res. 2000;43:769-781.</Citation></Reference><Reference><Citation>Turner GS, Tjaden K, Weismer G. The influence of speaking rate on vowel space and speech intelligibility for individuals with amyotrophic lateral sclerosis. J Speech Lang Hear Res. 1995;38:1001-1013.</Citation></Reference><Reference><Citation>Yunusova Y, Green JR, Greenwood L, Wang J, Pattee GL, Zinman L. Tongue movements and their acoustic consequences in amyotrophic lateral sclerosis. Folia Phoniatr Logop. 2012;64:94-102.</Citation></Reference><Reference><Citation>Yunusova Y, Rosenthal J, Green J, et al. Detection of bulbar ALS using a comprehensive speech assessment battery. In Proc of the International Workshop on Models and Analysis of Vocal Emissions for Biomedical Applications; 2013. p. 217-20.</Citation></Reference><Reference><Citation>Yunusova Y, Graham NL, Shellikeri S, et al. Profiling speech and pausing in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). PLoS One. 2016;11:e0147573.</Citation></Reference><Reference><Citation>Shellikeri S, Green JR, Kulkarni M, et al. Speech movement measures as markers of bulbar disease in amyotrophic lateral sclerosis. J Speech Lang Hear Res. 2016;59:887-899.</Citation></Reference><Reference><Citation>Weismer G, Martin R, Kent RD, Kent JF. Formant trajectory characteristics of males with amyotrophic lateral sclerosis. J Acoust Soc Am. 1992;91:1085-1098.</Citation></Reference><Reference><Citation>Lee J, Littlejohn MA, Simmons Z. Acoustic and tongue kinematic vowel space in speakers with and without dysarthria. Int J Speech Lang Pathol. 2017;19:195-204.</Citation></Reference><Reference><Citation>Ball LJ, Willis A, Beukelman DR, Pattee GL. A protocol for identification of early bulbar signs in amyotrophic lateral sclerosis. J Neurol Sci. 2001;191:43-53.</Citation></Reference><Reference><Citation>Ball LJ, Beukelman DR, Pattee GL. Timing of speech deterioration in people with amyotrophic lateral sclerosis. Am J Speech Lang Pathol. 2002;10:231-236.</Citation></Reference><Reference><Citation>Mefferd A. Articulatory-to-acoustic relations in talkers with dysarthria: a first analysis. J Speech Lang Hear Res. 2015;58:576-589.</Citation></Reference><Reference><Citation>Green JR, Beukelman DR, Ball LJ. Algorithmic estimation of pauses in extended speech samples of dysarthric and typical speech. Am J Speech Lang Pathol. 2004;12:149.</Citation></Reference><Reference><Citation>Barnett C, Green JR, Marzouqah R, et al. Reliability and validity of speech &amp; pause measures during passage reading in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:42-50.</Citation></Reference><Reference><Citation>Lee J, Bell M. Articulatory range of movement in individuals with dysarthria secondary to amyotrophic lateral sclerosis. Am J Speech Lang Pathol. 2018;27:996-1009.</Citation></Reference><Reference><Citation>Lee J, Rodriguez E, Mefferd A. Direction-specific jaw dysfunction and its impact on tongue movement in individuals with dysarthria secondary to amyotrophic lateral sclerosis. J Speech Lang Hear Res. 2020;63:499-508.</Citation></Reference><Reference><Citation>Mefferd AS, Dietrich MS. Tongue-and jaw-specific articulatory changes and their acoustic consequences in talkers with dysarthria due to amyotrophic lateral sclerosis: effects of loud, clear, and slow speech. J Speech Lang Hear Res. 2020;63:2625-2636.</Citation></Reference><Reference><Citation>Mefferd AS, Green JR, Pattee G. A novel fixed-target task to determine articulatory speed constraints in persons with amyotrophic lateral sclerosis. J Commun Disord. 2012;45:35-45.</Citation></Reference><Reference><Citation>Rong P, Green JR. Predicting speech intelligibility based on spatial tongue-jaw coupling in persons with amyotrophic lateral sclerosis: the impact of tongue weakness and jaw adaptation. J Speech Lang Hear Res. 2019;62:3085-3103.</Citation></Reference><Reference><Citation>Yunusova Y, Green JR, Lindstrom MJ, Ball LJ, Pattee GL, Zinman L. Kinematics of disease progression in bulbar ALS. J Commun Disord. 2010;43:6-20.</Citation></Reference><Reference><Citation>Lee J, Bell M, Simmons Z. Articulatory kinematic characteristics across the dysarthria severity spectrum in individuals with amyotrophic lateral sclerosis. Am J Speech Lang Pathol. 2018;27:258-269.</Citation></Reference><Reference><Citation>Bandini A, Green JR, Wang J, Campbell TF, Zinman L, Yunusova Y. Kinematic features of jaw and lips distinguish symptomatic from presymptomatic stages of bulbar decline in amyotrophic lateral sclerosis. J Speech Lang Hear Res. 2018;61:1118-1129.</Citation></Reference><Reference><Citation>DePaul R, Brooks BR. Multiple orofacial indices in amyotrophic lateral sclerosis. J Speech Lang Hear Res. 1993;36:1158-1167.</Citation></Reference><Reference><Citation>Dworkin JP, Aronson AE, Mulder DW. Tongue force in normals and in dysarthric patients with amyotrophic lateral sclerosis. J Speech Lang Hear Res. 1980;23:828-837.</Citation></Reference><Reference><Citation>Langmore SE, Lehman ME. Physiologic deficits in the orofacial system underlying dysarthria in amyotrophic lateral sclerosis. J Speech Lang Hear Res. 1994;37:28-37.</Citation></Reference><Reference><Citation>Searl J, Knollhoff S. Changes in lingual-alveolar contact pressure during speech over six months in amyotrophic lateral sclerosis. J Commun Disord. 2017;70:49-60.</Citation></Reference><Reference><Citation>Searl J, Knollhoff S. Articulation contact pressures scaled to the physiologic range of the tongue in amyotrophic lateral sclerosis: a pilot study. J Commun Disord. 2019;82:105937.</Citation></Reference><Reference><Citation>Searl J, Knollhoff S, Barohn RJ. Lingual-alveolar contact pressure during speech in amyotrophic lateral sclerosis: preliminary findings. J Speech Lang Hear Res. 2017;60:810-825.</Citation></Reference><Reference><Citation>Rong P, Yunusova Y, Richburg B, Green JR. Automatic extraction of abnormal lip movement features from the alternating motion rate task in amyotrophic lateral sclerosis. Int J Speech Lang Pathol. 2018;20:610-623.</Citation></Reference><Reference><Citation>Mefferd AS, Pattee GL, Green JR. Speaking rate effects on articulatory pattern consistency in talkers with mild ALS. Clin Linguist Phon. 2014;28:799-811.</Citation></Reference><Reference><Citation>Plowman EK, Tabor LC, Wymer J, Pattee G. The evaluation of bulbar dysfunction in amyotrophic lateral sclerosis: survey of clinical practice patterns in the United States. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:351-357.</Citation></Reference><Reference><Citation>Miller N. Measuring up to speech intelligibility. Int J Lang Commun Disord. 2013;48:601-612.</Citation></Reference><Reference><Citation>Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet. 2007;369:2031-2041.</Citation></Reference><Reference><Citation>Chio A, Logroscino G, Hardiman O, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310-323.</Citation></Reference><Reference><Citation>Burkhardt C, Neuwirth C, Sommacal A, Andersen PM, Weber M. Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients. PLoS One. 2017;12:e0177555.</Citation></Reference><Reference><Citation>Desport JC, Preux P, Truong T, Vallat J, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology. 1999;53:1059.</Citation></Reference><Reference><Citation>Diagnosis ETFo, Sclerosis: MoAL, Andersen PM, Abrahams S, Borasio GD, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force. Eur J Neurol. 2012;19:360-375.</Citation></Reference><Reference><Citation>Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73:1218-1226.</Citation></Reference><Reference><Citation>Groher MaC MA. Dysphagia: Clinical Management in Adults and Children. 2nd ed. Maryland Heights, MO: Mosby; 2015.</Citation></Reference><Reference><Citation>Pattee GL, Plowman EK, Brooks BR, et al. Best practices protocol for the evaluation of bulbar dysfunction: summary recommendations from the NEALS bulbar subcommittee symposium. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:311-312.</Citation></Reference><Reference><Citation>Maier A, Spittel S, Funke A, Kettemann D, M&#xfc;nch C, Meyer T. P43. Dysphagia and difficulties with tablet intake in ALS - assessment from the patient perspective. Clin Neurophysiol. 2018;129:e84-e85.</Citation></Reference><Reference><Citation>Luchesi KF, Kitamura S, Mour&#xe3;o LF. Higher risk of complications in odynophagia-associated dysphagia in amyotrophic lateral sclerosis. Arq Neuropsiquiatr. 2014;72:203-207.</Citation></Reference><Reference><Citation>Plowman EK, Tabor L, Robison R, et al. Discriminant ability of the eating assessment tool-10 to detect aspiration in individuals with amyotrophic lateral sclerosis. Neurogastroenterol Motil. 2016;28:85-90.</Citation></Reference><Reference><Citation>Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A penetration-aspiration scale. Dysphagia. 1996;11:93-98.</Citation></Reference><Reference><Citation>Wada A, Kawakami M, Liu M, et al. Development of a new scale for dysphagia in patients with progressive neuromuscular diseases: the neuromuscular disease swallowing status scale (NdSSS). J Neurol. 2015;262:2225-2231.</Citation></Reference><Reference><Citation>Hillel AD, Miller RM, Yorkston K, McDonald E, Norris FH, Konikow N. Amyotrophic lateral sclerosis severity scale. Neuroepidemiology. 1989;8:142-150.</Citation></Reference><Reference><Citation>Higo R, Tayama N, Nito T. Longitudinal analysis of progression of dysphagia in amyotrophic lateral sclerosis. Auris Nasus Larynx. 2004;31:247-254.</Citation></Reference><Reference><Citation>Onesti E, Schettino I, Gori MC, et al. Dysphagia in amyotrophic lateral sclerosis: impact on patient behavior, diet adaptation, and riluzole management. Front Neurol. 2017;8:94.</Citation></Reference><Reference><Citation>Spataro R, Ficano L, Piccoli F, La Bella V. Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: effect on survival. J Neurol Sci. 2011;304:44-48.</Citation></Reference><Reference><Citation>Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73:1218-1226.</Citation></Reference><Reference><Citation>K&#xf6;rner S, Hendricks M, Kollewe K, et al. Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options. BMC Neurol. 2013;13:84.</Citation></Reference><Reference><Citation>Komiya K, Ishii H, Kadota J-i. Healthcare-associated pneumonia and aspiration pneumonia. Aging Dis. 2015;6:27.</Citation></Reference><Reference><Citation>Troche MS, Brandimore AE, Godoy J, Hegland KW. A framework for understanding shared substrates of airway protection. J Appl Oral Sci. 2014;22:251-260.</Citation></Reference><Reference><Citation>Erdem NS, Karaali K, &#xdc;nal A, K&#x131;z&#x131;lay F, &#xd6;&#x11f;&#xfc;&#x15f; C, Uysal H. The interaction between breathing and swallowing in amyotrophic lateral sclerosis. Acta Neurol Belg. 2016;116:549-556.</Citation></Reference><Reference><Citation>Paris G, Martinaud O, Hannequin D, et al. Clinical screening of oropharyngeal dysphagia in patients with ALS. Ann Phys Rehabil Med. 2012;55:601-608.</Citation></Reference><Reference><Citation>Tabor-Gray L, Vasilopoulos T, Plowman EK. Concordant validity of a digital peak cough flow meter to assess voluntary cough strength in individuals with ALS. Dysphagia. 2020;35:568-573.</Citation></Reference><Reference><Citation>Smith RA, Macklin EA, Myers KJ, et al. Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self-report scale (Center for Neurologic Study Bulbar Function Scale). Eur J Neurol. 2018;25:907-e66.</Citation></Reference><Reference><Citation>Weikamp JG, Schelhaas HJ, Hendriks JCM, de Swart BJM, Geurts ACH. Prognostic value of decreased tongue strength on survival time in patients with amyotrophic lateral sclerosis. J Neurol. 2012;259:2360-2365.</Citation></Reference><Reference><Citation>Yeates EM, Molfenter SM, Steele CM. Improvements in tongue strength and pressure-generation precision following a tongue-pressure training protocol in older individuals with dysphagia: three case reports. Clin Interv Aging. 2008;3:735-747.</Citation></Reference><Reference><Citation>Hiraoka A, Yoshikawa M, Nakamori M, et al. Maximum tongue pressure is associated with swallowing dysfunction in ALS patients. Dysphagia. 2017;32:542-547.</Citation></Reference><Reference><Citation>Borges ALF, Velasco LC, Ramos HVL, et al. Association between dysphagia and tongue strength in patients with amyotrophic lateral sclerosis. Braz J Otorhinolaryngol. 2020. https://doi.org/10.1016/j.bjorl.2020.10.015.</Citation></Reference><Reference><Citation>Koch I, Ferrazzi A, Busatto C, et al. Cranial nerve examination for neurogenic dysphagia patients. Otolaryngology (Sunnyvale). 2017;7:2.</Citation></Reference><Reference><Citation>Suiter DM, Sloggy J, Leder SB. Validation of the Yale Swallow Protocol: a prospective double-blinded videofluoroscopic study. Dysphagia. 2014;29:199-203.</Citation></Reference><Reference><Citation>Aydougdu I, Zeynep Tanriverdi CE. Dysfunction of bulbar central pattern generator in ALS patients with dysphagia during sequential deglutition. Clin Neurophysiol. 2011;122:1219-1228.</Citation></Reference><Reference><Citation>Solazzo A, Monaco L, Del Vecchio L, et al. Earliest videofluoromanometric pharyngeal signs of dysphagia in ALS patients. Dysphagia. 2014;29:539-544.</Citation></Reference><Reference><Citation>Kawai S, Tsukuda M, Mochimatsu I, et al. A study of the early stage of dysphagia in amyotrophic lateral sclerosis. Dysphagia. 2003;18:1-8.</Citation></Reference><Reference><Citation>Waito AA, Tabor-Gray LC, Steele CM, Plowman EK. Reduced pharyngeal constriction is associated with impaired swallowing efficiency in amyotrophic lateral sclerosis (ALS). Neurogastroenterol Motil. 2018;30:e13450.</Citation></Reference><Reference><Citation>Briani C, Marcon M, Ermani M, et al. Radiological evidence of subclinical dysphagia in motor neuron disease. J Neurol. 1998;245:211-216.</Citation></Reference><Reference><Citation>Cosentino G, Alfonsi E, Mainardi L, et al. The importance of the reproducibility of oropharyngeal swallowing in amyotrophic lateral sclerosis. An electrophysiological study. Clin Neurophysiol. 2017;128:792-798.</Citation></Reference><Reference><Citation>Amin MR, Harris D, Cassel SG, Grimes E, Heiman-Patterson T. Sensory testing in the assessment of laryngeal sensation in patients with amyotrophic lateral sclerosis. Ann Otol Rhinol Laryngol. 2006;115:528-534.</Citation></Reference><Reference><Citation>Pikus L, Levine MS, Yang YX, et al. Videofluoroscopic studies of swallowing dysfunction and the relative risk of pneumonia. AJR Am J Roentgenol. 2003;180:1613-1616.</Citation></Reference><Reference><Citation>Tamburrini S, Solazzo A, Sagnelli A, et al. Amyotrophic lateral sclerosis: sonographic evaluation of dysphagia. Radiol Med. 2010;115:784-793.</Citation></Reference><Reference><Citation>Rong P, Yunusova Y, Wang J, et al. Predicting speech intelligibility decline in amyotrophic lateral sclerosis based on the deterioration of individual speech subsystems. PLoS One. 2016;11:e0154971.</Citation></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS study group (phase III). J Neurol Sci. 1999;169:13-21.</Citation></Reference><Reference><Citation>Ramsey DJ, Smithard DG, Kalra L. Early assessments of dysphagia and aspiration risk in acute stroke patients. Stroke. 2003;34:1252-1257.</Citation></Reference><Reference><Citation>Gaziano J, Tabor L, Richter J, Plowman E. Prevalence, timing and source of aspiration in individuals with ALS. Dysphagia Research Society. 2015.</Citation></Reference><Reference><Citation>Epps D, Kwan JY, Russell JW, Thomas T, Diaz-Abad M. Evaluation and management of dysphagia in amyotrophic lateral sclerosis: a survey of speech-language pathologists' clinical practice. J Clin Neuromuscul Dis. 2020;21:135-143.</Citation></Reference><Reference><Citation>O'Horo JC, Rogus-Pulia N, Garcia-Arguello L, Robbins J, Safdar N. Bedside diagnosis of dysphagia: a systematic review. J Hosp Med. 2015;10:256-265.</Citation></Reference><Reference><Citation>Mann G. MASA: The Mann Assessment of Swallowing Ability. Clifton (NY): Tomson Learning Inc; 2002.</Citation></Reference><Reference><Citation>Dua K, Surapaneni SN, Kuribayashi S, Hafeezullah M, Shaker R. Protective role of aerodigestive reflexes against aspiration: study on subjects with impaired and preserved reflexes. Gastroenterology. 2011;140:1927-1933.</Citation></Reference><Reference><Citation>Crary MA, Carnaby GD, Sia I, Khanna A, Waters MF. Spontaneous swallowing frequency has potential to identify dysphagia in acute stroke. Stroke. 2013;44:3452-3457.</Citation></Reference><Reference><Citation>*Bunton K, Kent RD, Kent JF, Rosenbek JC. Perceptuo-acoustic assessment of prosodic impairment in dysarthria. Clin Linguist Phon. 2000;14:13-24.</Citation></Reference><Reference><Citation>*Hlavni&#x10d;ka J, Tykalov&#xe1; T, Ulmanov&#xe1; O, et al. Characterizing vocal tremor in progressive neurological diseases via automated acoustic analyses. Clin Neurophysiol. 2020;131:1155-1165.</Citation></Reference><Reference><Citation>*Lee J, Kim H, Jung Y. Patterns of misidentified vowels in individuals with dysarthria secondary to amyotrophic lateral sclerosis. J Speech Lang Hear Res. 2020;63:2649-2666.</Citation></Reference><Reference><Citation>*Makkonen T, Korpijaakko-Huuhka A-M, Ruottinen H, et al. Oral motor functions, speech and communication before a definitive diagnosis of amyotrophic lateral sclerosis. J Commun Disord. 2016;61:97-105.</Citation></Reference><Reference><Citation>*Makkonen T, Ruottinen H, Puhto R, Helminen M, Palmio J. Speech deterioration in amyotrophic lateral sclerosis (ALS) after manifestation of bulbar symptoms. Int J Lang Commun Disord. 2018;53:385-392.</Citation></Reference><Reference><Citation>*Rong P, Yunusova Y, Wang J, Green JR. Predicting early bulbar decline in amyotrophic lateral sclerosis: a speech subsystem approach. Behav Neurol. 2015;2015:1-11.</Citation></Reference><Reference><Citation>*Turner GS, Weismer G. Characteristics of speaking rate in the dysarthria associated with amyotrophic lateral sclerosis. J Speech Lang Hear Res. 1993;36:1134-1144.</Citation></Reference><Reference><Citation>*Weismer G, Laures JS, Jeng J-Y, Kent RD, Kent JF. Effect of speaking rate manipulations on acoustic and perceptual aspects of the dysarthria in amyotrophic lateral sclerosis. Folia Phoniatr Logop. 2000;52:201-219.</Citation></Reference><Reference><Citation>*Eshghi M, Stipancic KL, Mefferd A, et al. Assessing oromotor capacity in ALS: the effect of a fixed-target task on lip biomechanics. Front Neurol. 2019;10:1288.</Citation></Reference><Reference><Citation>*Kuruvilla MS, Green JR, Yunusova Y, Hanford K. Spatiotemporal coupling of the tongue in amyotrophic lateral sclerosis. J Speech Lang Hear Res. 2012;55:1897-1909.</Citation></Reference><Reference><Citation>*Kuruvilla-Dugdale M, Mefferd A. Spatiotemporal movement variability in ALS: speaking rate effects on tongue, lower lip, and jaw motor control. J Commun Disord. 2017;67:22-34.</Citation></Reference><Reference><Citation>*Weismer G, Yunusova Y, Westbury JR. Interarticulator coordination in dysarthria: an X-ray microbeam study. J Speech Lang Hear Res. 2003;46:1247-1261.</Citation></Reference><Reference><Citation>*Yunusova Y, Weismer G, Westbury JR, Lindstrom MJ. Articulatory movements during vowels in speakers with dysarthria and healthy controls. J Speech Lang Hear Res. 2008.51 596-611.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>